Drug Research
uMotif collaborates with The University of Manchester on body mapping tool to accelerate pain reporting for people living with musculoskeletal conditions
uMotif, a leading eClinical platform provider powering patient-centric research, has joined up with researchers at The University of Manchester to investigate the real-world usability of its digital body mapping tool in a feasibility study in people living with musculoskeletal...
Drug Research
Swiss CDMO Invests in Powder Containment and Extends Spray Drying Capabilities
Micro-Sphere has added to its contract development and manufacturing expertise with new spray drying technology and increased high containment capabilities.
The Swiss contract development and manufacturing organisation (CDMO), which specialises in spray drying and capsule filling, has invested more than...
Drug Research
Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services
Aragen Life Sciences (formerly, GVK BIO), a leading partner offering R&D and Manufacturing solutions (CRO/CDMO) for life sciences industries worldwide, expects high teens growth in 2022, with NCE development and manufacturing business growing at circa 40% year-on-year.
The company, states...
Drug Research
AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research Through 2025
AbbVie and the University of Chicago and have extended their collaboration agreement through 2025 to support preclinical oncology research.
To date, the collaboration has led to novel insights related to biomarkers and therapeutic applications for existing AbbVie programs. This has...
Drug Research
Biognosys Launches Next-Generation Blood Biomarker Discovery Solution
Biognosys, a leader in proteomics solutions for drug discovery and development, announces the launch of its next-generation blood biomarker discovery solution, which will be offered as a contract research service. The service is designed to help researchers decipher the...
Drug Research
Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States
Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a strategic commercialization arrangement for rimegepant in markets outside of the United States upon approval. Rimegepant is commercialized as Nurtec® ODT in the U.S., and is indicated for the acute...
Drug Research
Phillips-Medisize and Exact Sciences Collaborate to Fight Colorectal Cancer
Phillips-Medisize, a Molex company and leader in drug delivery, diagnostic and MedTech devices, announces the successful collaboration with Exact Sciences, a global leader in cancer diagnostics, to advance early cancer detection. Fueled by a relentless pursuit for smarter, earlier...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
